Cargando…

Cyclooxygenase-2 expression in oligodendrocytes increases sensitivity to excitotoxic death

BACKGROUND: We previously found that cyclooxygenase 2 (COX-2) was expressed in dying oligodendrocytes at the onset of demyelination in the Theiler's murine encephalomyelitis virus-induced demyelinating disease (TMEV-IDD) model of multiple sclerosis (MS) (Carlson et al. J.Neuroimmunology 2006, 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Carlson, Noel G, Rojas, Monica A, Redd, Jonathan W, Tang, Philip, Wood, Blair, Hill, Kenneth E, Rose, John W
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2873241/
https://www.ncbi.nlm.nih.gov/pubmed/20388219
http://dx.doi.org/10.1186/1742-2094-7-25
_version_ 1782181294666416128
author Carlson, Noel G
Rojas, Monica A
Redd, Jonathan W
Tang, Philip
Wood, Blair
Hill, Kenneth E
Rose, John W
author_facet Carlson, Noel G
Rojas, Monica A
Redd, Jonathan W
Tang, Philip
Wood, Blair
Hill, Kenneth E
Rose, John W
author_sort Carlson, Noel G
collection PubMed
description BACKGROUND: We previously found that cyclooxygenase 2 (COX-2) was expressed in dying oligodendrocytes at the onset of demyelination in the Theiler's murine encephalomyelitis virus-induced demyelinating disease (TMEV-IDD) model of multiple sclerosis (MS) (Carlson et al. J.Neuroimmunology 2006, 149:40). This suggests that COX-2 may contribute to death of oligodendrocytes. OBJECTIVE: The goal of this study was to examine whether COX-2 contributes to excitotoxic death of oligodendrocytes and potentially contributes to demyelination. METHODS: The potential link between COX-2 and oligodendrocyte death was approached using histopathology of MS lesions to examine whether COX-2 was expressed in dying oligodendrocytes. COX-2 inhibitors were examined for their ability to limit demyelination in the TMEV-IDD model of MS and to limit excitotoxic death of oligodendrocytes in vitro. Genetic manipulation of COX-2 expression was used to determine whether COX-2 contributes to excitotoxic death of oligodendrocytes. A transgenic mouse line was generated that overexpressed COX-2 in oligodendrocytes. Oligodendrocyte cultures derived from these transgenic mice were used to examine whether increased expression of COX-2 enhanced the vulnerability of oligodendrocytes to excitotoxic death. Oligodendrocytes derived from COX-2 knockout mice were evaluated to determine if decreased COX-2 expression promotes a greater resistance to excitotoxic death. RESULTS: COX-2 was expressed in dying oligodendrocytes in MS lesions. COX-2 inhibitors limited demyelination in the TMEV-IDD model of MS and protected oligodendrocytes against excitotoxic death in vitro. COX-2 expression was increased in wild-type oligodendrocytes following treatment with Kainic acid (KA). Overexpression of COX-2 in oligodendrocytes increased the sensitivity of oligodendrocytes to KA-induced excitotoxic death eight-fold compared to wild-type. Conversely, oligodendrocytes prepared from COX-2 knockout mice showed a significant decrease in sensitivity to KA induced death. CONCLUSIONS: COX-2 expression was associated with dying oligodendrocytes in MS lesions and appeared to increase excitotoxic death of oligodendrocytes in culture. An understanding of how COX-2 expression influences oligodendrocyte death leading to demyelination may have important ramifications for future treatments for MS.
format Text
id pubmed-2873241
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-28732412010-05-20 Cyclooxygenase-2 expression in oligodendrocytes increases sensitivity to excitotoxic death Carlson, Noel G Rojas, Monica A Redd, Jonathan W Tang, Philip Wood, Blair Hill, Kenneth E Rose, John W J Neuroinflammation Research BACKGROUND: We previously found that cyclooxygenase 2 (COX-2) was expressed in dying oligodendrocytes at the onset of demyelination in the Theiler's murine encephalomyelitis virus-induced demyelinating disease (TMEV-IDD) model of multiple sclerosis (MS) (Carlson et al. J.Neuroimmunology 2006, 149:40). This suggests that COX-2 may contribute to death of oligodendrocytes. OBJECTIVE: The goal of this study was to examine whether COX-2 contributes to excitotoxic death of oligodendrocytes and potentially contributes to demyelination. METHODS: The potential link between COX-2 and oligodendrocyte death was approached using histopathology of MS lesions to examine whether COX-2 was expressed in dying oligodendrocytes. COX-2 inhibitors were examined for their ability to limit demyelination in the TMEV-IDD model of MS and to limit excitotoxic death of oligodendrocytes in vitro. Genetic manipulation of COX-2 expression was used to determine whether COX-2 contributes to excitotoxic death of oligodendrocytes. A transgenic mouse line was generated that overexpressed COX-2 in oligodendrocytes. Oligodendrocyte cultures derived from these transgenic mice were used to examine whether increased expression of COX-2 enhanced the vulnerability of oligodendrocytes to excitotoxic death. Oligodendrocytes derived from COX-2 knockout mice were evaluated to determine if decreased COX-2 expression promotes a greater resistance to excitotoxic death. RESULTS: COX-2 was expressed in dying oligodendrocytes in MS lesions. COX-2 inhibitors limited demyelination in the TMEV-IDD model of MS and protected oligodendrocytes against excitotoxic death in vitro. COX-2 expression was increased in wild-type oligodendrocytes following treatment with Kainic acid (KA). Overexpression of COX-2 in oligodendrocytes increased the sensitivity of oligodendrocytes to KA-induced excitotoxic death eight-fold compared to wild-type. Conversely, oligodendrocytes prepared from COX-2 knockout mice showed a significant decrease in sensitivity to KA induced death. CONCLUSIONS: COX-2 expression was associated with dying oligodendrocytes in MS lesions and appeared to increase excitotoxic death of oligodendrocytes in culture. An understanding of how COX-2 expression influences oligodendrocyte death leading to demyelination may have important ramifications for future treatments for MS. BioMed Central 2010-04-13 /pmc/articles/PMC2873241/ /pubmed/20388219 http://dx.doi.org/10.1186/1742-2094-7-25 Text en Copyright ©2010 Carlson et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Carlson, Noel G
Rojas, Monica A
Redd, Jonathan W
Tang, Philip
Wood, Blair
Hill, Kenneth E
Rose, John W
Cyclooxygenase-2 expression in oligodendrocytes increases sensitivity to excitotoxic death
title Cyclooxygenase-2 expression in oligodendrocytes increases sensitivity to excitotoxic death
title_full Cyclooxygenase-2 expression in oligodendrocytes increases sensitivity to excitotoxic death
title_fullStr Cyclooxygenase-2 expression in oligodendrocytes increases sensitivity to excitotoxic death
title_full_unstemmed Cyclooxygenase-2 expression in oligodendrocytes increases sensitivity to excitotoxic death
title_short Cyclooxygenase-2 expression in oligodendrocytes increases sensitivity to excitotoxic death
title_sort cyclooxygenase-2 expression in oligodendrocytes increases sensitivity to excitotoxic death
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2873241/
https://www.ncbi.nlm.nih.gov/pubmed/20388219
http://dx.doi.org/10.1186/1742-2094-7-25
work_keys_str_mv AT carlsonnoelg cyclooxygenase2expressioninoligodendrocytesincreasessensitivitytoexcitotoxicdeath
AT rojasmonicaa cyclooxygenase2expressioninoligodendrocytesincreasessensitivitytoexcitotoxicdeath
AT reddjonathanw cyclooxygenase2expressioninoligodendrocytesincreasessensitivitytoexcitotoxicdeath
AT tangphilip cyclooxygenase2expressioninoligodendrocytesincreasessensitivitytoexcitotoxicdeath
AT woodblair cyclooxygenase2expressioninoligodendrocytesincreasessensitivitytoexcitotoxicdeath
AT hillkennethe cyclooxygenase2expressioninoligodendrocytesincreasessensitivitytoexcitotoxicdeath
AT rosejohnw cyclooxygenase2expressioninoligodendrocytesincreasessensitivitytoexcitotoxicdeath